menu
    • menu

    Company profile for Genprex

    NEW Drugs in Dev: 5
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Genprex is a clinical stage gene therapy company committed to pioneering a new approach to treating cancer. We are developing potentially life-changing gene technologies based upon our novel proprietary technology platform, including our initial product candidate, Oncoprex™ immunogene therapy, or Oncoprex. Our platform technologies are designed to administer cancer fighting genes by encapsulating them into nanoscale hollow s...
    Genprex is a clinical stage gene therapy company committed to pioneering a new approach to treating cancer. We are developing potentially life-changing gene technologies based upon our novel proprietary technology platform, including our initial product candidate, Oncoprex™ immunogene therapy, or Oncoprex. Our platform technologies are designed to administer cancer fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles. The nanovesicles are then administered intravenously and are taken up by tumor cells where they express proteins that are missing or found in low quantities.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    GenprexUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Dell Medical Center Health Discovery Building 1601 Trinity Street, Bldg B Suit...
    Telephone
    Telephone
    (877) 774-GNPX (4679)
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.genprex.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/genprex
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/genprex

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Product Expo West

    Natural Product Expo West

    Not Confirmed

    envelop Contact Supplier

    Natural Product Expo West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Genprex To Receive Patent In Australia For Reqorsa Gene Therapy
    Genprex To Receive Patent In Australia For Reqorsa Gene Therapy

    10 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/genprex-announces-ip-australias-intent-to-grant-patent-for-reqorsa-gene-therapy-in-combination-with-pd-l1-antibodies-to-treat-cancers-302683580.html

    PR NEWSWIRE
    10 Feb 2026
    Share Share
    Genprex Provides Clinical Update On Diabetes Gene Therapy Program
    Genprex Provides Clinical Update On Diabetes Gene Therapy Program

    07 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/genprex-provides-clinical-update-on-diabetes-gene-therapy-program-302654680.html

    PR NEWSWIRE
    07 Jan 2026
    Share Share
    Genprex Reveals Promising Preclinical Results For GPX-002
    Genprex Reveals Promising Preclinical Results For GPX-002

    06 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/genprex-announces-positive-preliminary-preclinical-data-from-study-of-gpx-002-in-type-2-diabetic-animal-studies-302653395.html

    PR NEWSWIRE
    06 Jan 2026
    Share Share
    Genprex Releases Acclaim-1 Gene Therapy Trial Data In Lung Cancer
    Genprex Releases Acclaim-1 Gene Therapy Trial Data In Lung Cancer

    24 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/data-from-genprexs-acclaim-1-phase-1-gene-therapy-clinical-trial-published-in-clinical-lung-cancer-302623852.html

    PR NEWSWIRE
    24 Nov 2025
    Share Share
    Genprex Expands Clinical Trial Sites For Acclaim-1 & Acclaim-3
    Genprex Expands Clinical Trial Sites For Acclaim-1 & Acclaim-3

    19 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/genprex-adds-clinical-trial-site-for-acclaim-1-and-acclaim-3-lung-cancer-clinical-trials-302619903.html

    PR NEWSWIRE
    19 Nov 2025
    Share Share
    Genprex Secures U.S. Patent for Reqorsa in PD-L1-Positive Cancers
    Genprex Secures U.S. Patent for Reqorsa in PD-L1-Positive Cancers

    18 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/genprex-announces-us-patent-for-reqorsa-gene-therapy-in-combination-with-pd-l1-antibodies-to-treat-cancers-302617555.html

    PR NEWSWIRE
    18 Nov 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search